Trials / Active Not Recruiting

Active Not RecruitingNCT07044141

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

Efficacy of Oral Tofacitinib in Combination With Narrow Band UVB in the Treatment of Vitiligo

Status: Active Not Recruiting
Phase: Phase 1
Study type: Interventional
Enrollment: 20 (estimated)

Sponsor: Lahore General Hospital · Other Government
Sex: All
Age: 18 Years – 60 Years
Healthy volunteers: Not accepted

Summary

20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine . 10 will be given tofacitinib

Detailed description

Total 20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine 50mg twice daily. 10 will be given tofacitinib 5mg twice daily. For 6 months

Conditions

Vitiligo

Interventions

Type	Name	Description
DRUG	Azathioprine	azathioprine 50mg twice daily will be given
DRUG	Tofacitinib	It is a janus kinase inhibitor

Timeline

Start date: 2025-03-01
Primary completion: 2025-09-30
Completion: 2025-09-30
First posted: 2025-06-29
Last updated: 2025-06-29

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07044141. Inclusion in this directory is not an endorsement.